Clinical Trials in New York

Showing 20321-20340 of 22,668 trials

PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

NCT00045279

RATIONALE: PEG-interferon alfa-2b may stop the growth of kidney cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of PEG-interferon alfa-2b in treating patients who have metastatic kidney cancer.

Kidney Cancer

Memorial Sloan Kettering Cancer CenterStarted Apr 2002

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

NCT00397787

This phase II trial is studying how well sunitinib works in treating patients with metastatic pancreatic cancer that progressed after first-line therapy with gemcitabine. Sunitinib may stop the growth of pancreatic cancer by blocking blood flow to the tumor and by blocking some of the enzymes needed for cell growth.

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more

National Cancer Institute (NCI)64 participantsStarted Nov 2006

Chicago, Illinois, United States • New York, New York, United States

COMPLETEDPhase 2< 1 mile

Oblimersen in Treating Patients With Merkel Cell Carcinoma

NCT00079131

This phase II trial is studying how well oblimersen works in treating patients with Merkel cell cancer. Biological therapies, such as oblimersen, may interfere with the growth of tumor cells and slow the growth of Merkel cell carcinoma (skin cancer).

Recurrent Neuroendocrine Carcinoma of the SkinStage I Neuroendocrine Carcinoma of the SkinStage II Neuroendocrine Carcinoma of the Skin+2 more

National Cancer Institute (NCI)37 participantsStarted Jan 2004

New York, New York, United States

PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

Oblimersen in Treating Patients With Merkel Cell Carcinoma

Find Trials by Condition in New York

Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival

Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

An Innovative HIV Prevention Intervention Using Social Networking Technology

Objective Testing of Tear Film Stability

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy

A Pivotal Study to Evaluate the Safety and Effectiveness of RMT Medical Technology's SafeFlo® Vena Cava Filter

Fecal Biomarker Study for Patients With Ulcerative Colitis

Stress Management Training in Patients Undergoing Radiation Therapy for Cancer

Post Kidney Transplant Nocturnal Hypertension Prevalence and Management Study

Ocular Allergy Treatment Practical Impact Trial

Pilot Study to Determine Efficacy of Cyclamen Europaeum Extract Nasal Spray in Patients With Acute Sinusitis

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide

Clinical Efficacy Study Comparing VisionScope Imaging (VSI) to Magnetic Resonance Imaging (MRI) in Injuries of the Knee

Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors